Sales decline 16.01% to Rs 2.57 crore
Net Loss of Suven Life Sciences reported to Rs 49.64 crore in the quarter ended September 2024 as against net loss of Rs 12.68 crore during the previous quarter ended September 2023. Sales declined 16.01% to Rs 2.57 crore in the quarter ended September 2024 as against Rs 3.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales2.573.06 -16 OPM %-2031.52-768.30 -PBDT-48.19-18.41 -162 PBT-49.64-20.14 -146 NP-49.64-12.68 -291Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Dalal Street, Stock Market, Market, Crash, Funds, up, Stock, Gain, Lost, decline, statistic, Crisis, Capital, BSE, NSE")
 "Union Budget, Budget 2024, market, stock markets")
 "Indian Oil")
 "Amit Shah, Home Minister")
 "Delhi High Court")
